Nuvaira is a medical device company that develops therapies to improve outcomes for patients suffering from obstructive lung diseases by addressing underlying disease pathophysiology.
Minneapolis, Minnesota-based Nuvaira has raised $79 million in funding to further develop its novel therapeutic medical devices for treating obstructive lung diseases.
